Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers
Status:
Completed
Trial end date:
2015-07-06
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the effect of repeated doses of DS-8500a on
the single dose pharmacokinetics (PK) of rosuvastatin.
The total length of time (from screening to follow-up) for each participant is approximately
7 weeks.
It is expected that repeated oral doses of DS-8500a will not have a significant effect on the
pharmacokinetics of a single dose of rosuvastatin.